NTAP vs ZBIO · P/E 28, rev $6.24B vs rev $10.0M
NetApp Inc (NTAP) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the NTAP and ZBIO stock pages for the full models.
Not investment advice.